Please login to the form below

Not currently logged in
Email:
Password:

Immodulon

This page shows the latest Immodulon news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Immodulon Therapeutics bolsters senior team Immodulon Therapeutics bolsters senior team

    Independent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman. ... the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.

  • Immodulon Therapeutics appointments two new board of directors Immodulon Therapeutics appointments two new board of directors

    Anthony Bolton and Sir Simon Robertson join the biopharma firm. Immodulon Therapeutics, a privately held, late-stage biopharmaceutical company focused on immuno-oncology has made two new senior appointments to its ... Anthony Bolton, one of the UK's most

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...